Bioness Inc. today announced it has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) to market a smaller
leg cuff for use with the company’s L300® Foot Drop System. The L300 is a
neuromodulation technology designed to treat foot drop, a condition which
causes difficulty walking for those with upper motor neuron injury or disease
resulting from stroke, multiple sclerosis, traumatic brain injury, spinal cord
injury and cerebral palsy. The new cuff size provides access to the L300 for patients
with smaller calf sizes.
“While the L300 Foot Drop System has provided life-changing
benefits to many individuals suffering with debilitating neurological
conditions, we have always known that there are additional populations –
particularly individuals of smaller stature – who could benefit from this
device,” said Thomas G. Fogarty, president & CEO of Bioness. “With the
availability of a smaller cuff size with the L300 we hope to help many more
individuals regain mobility, restore confidence and get back their
independence, ultimately improving their quality of life.”
The L300 Foot Drop System can be used for mobility
rehabilitation in inpatient or outpatient rehabilitation settings, as well as
in the home, to help potentially realize a variety of clinical benefits
including improved mobility, maintaining or increasing range of motion,
re-educating muscles and preventing or slowing muscle loss.
Worn on the leg, the L300 has three main parts: a
small transmitter in the shoe, a leg cuff wrapped just below the knee and a
hand-held remote control. The three components use wireless communication to
“talk” to each other. When an individual tries to walk, the L300
sends low-level electrical stimulation to activate the nerves in the lower leg
which control the muscles responsible for lifting the foot, helping individuals
to walk and lessening the restrictions experienced with foot drop.
The smaller-size leg cuff is now available for purchase as
an upgrade to an existing L300 system, or with a new L300 program. Individuals
interested in more information can contact Bioness at 800-211-9136, Option
2.
About Bioness Inc.
Bioness develops and manufactures innovative, neuromodulation medical devices and
distributes rehabilitative technologies that help improve lives and restore
function for those living with neurological deficits and peripheral pain. The
company’s innovative neuromodulation products: the L300® Foot Drop
System, L300® Plus System, H200® Hand Rehabilitation System and H200® Wireless
Hand Rehabilitation System are cleared for use by the Food and Drug
Administration and help individuals with central nervous system disorders such
as stroke, multiple sclerosis, spinal cord injury and traumatic brain injury
regain movement in affected limbs. Bioness also distributes the Dynavision D2
and ZeroG which are rehabilitative technologies designed to help patients
achieve new levels of physical independence and productivity. Individual
results vary. Consult with a qualified physician to find out if these products
are right for you. Additional information about Bioness can be found at www.bioness.com.
